冠状动脉微血管功能障碍的代谢和蛋白质分析:从老鼠模型的见解
Yan Lu1, Yuying Wang1, Qiqi Xin1,2
1Laboratory of Cardiovascular Diseases, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China.
Biomolecules
|October 26, 2024
概括
冠状动脉微血管功能障碍 (CMD) 诊断可以通过新的蛋白质和代谢物生物标志物得到改善. 这项研究确定了四种关键蛋白质 (Emc1,Ank1,Fbln2,Hp) 和与大鼠CMD相关的代谢途径.
科学领域:
- 心血管研究研究心血管研究
- 生物标志物发现发现
- 蛋白质组学和代谢组学
背景情况:
- 冠状动脉微血管功能障碍 (CMD) 是缺血性心脏病的关键原因.
- 目前用于CMD的诊断方法不足,导致治疗延迟和死亡率增加.
- 需要改进的诊断工具来准确识别CMD患者.
研究的目的:
- 在大鼠模型中研究与CMD相关的不同代谢和蛋白质组概况.
- 确定新的诊断标记物,以提高CMD诊断的准确性.
- 探索CMD病变发生的潜在代谢机制.
主要方法:
- 使用栓塞微球建立一个CMD老鼠模型.
- 进行非向的代谢组学和乙化蛋白质组学分析.
- 使用机器学习 (拉索回归,SVM,随机森林) 来识别标记.
- 进行基因本体学和KEGG通路丰富分析.
主要成果:
- 鉴定了53种差异表达和模块化蛋白质.
- 确定四种核心蛋白 (Emc1,Ank1,Fbln2,Hp) 作为CMD强大的诊断标记物.
- 接收器操作特征 (ROC) 曲线分析证实了显著的诊断性能.
- 富化分析显示,DEP主要参与代谢途径,特别是三碳酸循环.
结论:
- 特定的蛋白质和代谢变化是CMD的特征.
- 鉴定的四种蛋白质显示出作为CMD可靠的诊断生物标志物的潜力.
- 三碳酸循环被认为是CMD中的一个中心代谢途径.
- 这些发现为改善CMD的诊断策略铺平了道路.
相关概念视频
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...


